| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |